Assignee
HISTOGEN INC
US·7 granted patents·7 pending applications·1 citations·filing 2009–2022
Top patents by PatentIndex Score
14 records- 0178US2022204921A1Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditionsHISTOGEN INC·Filed 2022·Application pending·0 cites
- 0276US9512403B2Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditions for methods of treating tissue injuryHISTOGEN INC·Filed 2013·Granted Dec 6, 2016·1 cites·11 claims
- 0370US11274276B2Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditionsHISTOGEN INC·Filed 2020·Granted Mar 15, 2022·0 cites·8 claims
- 0469US2010034787A1Composition and methods for promoting hair growthHISTOGEN INC·Filed 2009·Application pending·0 cites
- 0567US10143708B2Extracellular matrix compositions for the treatment of cancerHISTOGEN INC·Filed 2016·Granted Dec 4, 2018·0 cites·11 claims
- 0663US10538736B2Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditionsHISTOGEN INC·Filed 2016·Granted Jan 21, 2020·0 cites·7 claims
- 0762US9506038B2Extracellular matrix compositions for the treatment of cancerHISTOGEN INC·Filed 2015·Granted Nov 29, 2016·0 cites·14 claims
- 0855US11597703B2Caspase inhibitors and methods of use thereofHISTOGEN INC·Filed 2020·Granted Mar 7, 2023·0 cites·21 claims
- 0954US2021299036A1Conditioned medium and extracellular matrix compositions and uses thereofHISTOGEN INC·Filed 2019·Application pending·0 cites
- 1050US2010166824A1Extracellular matrix compositionsHISTOGEN INC·Filed 2009·Application pending·0 cites
- 1149US2022031760A1Compositions and methods for reducing inflammationHISTOGEN INC·Filed 2021·Application pending·0 cites
- 1248US2021038652A1Extracellular vesicles derived from cells cultured under hypoxic conditions and uses thereofHISTOGEN INC·Filed 2019·Application pending·0 cites
- 1346US2022211768A1Conditioned medium and methods of use thereofHISTOGEN INC·Filed 2020·Application pending·0 cites
- 1445US11447497B2(S)-3-(2-(4-(benzyl)-3-oxopiperazin-1-yl)acetamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid derivatives and related compounds as caspase inhibitors for treating cardiovascular diseasesHISTOGEN INC·Filed 2019·Granted Sep 20, 2022·0 cites·20 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →